Financial results - GENOME LIFE RESEARCH SRL

Financial Summary - Genome Life Research Srl
Unique identification code: 31166896
Registration number: J40/1193/2013
Nace: 7211
Sales - Ron
-
Net Profit - Ron
-3.065
Employees
Open Account
Company Genome Life Research Srl with Fiscal Code 31166896 recorded a turnover of 2024 of - , with a net profit of -3.065 and having an average number of employees of - . The company operates in the field of Cercetare-dezvoltare in biotehnologie having the NACE code 7211.
Sales - Ron

Sales, Profit, Employees, Total Income, Financial Results - Genome Life Research Srl

2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Sales - EUR 648 0 0 0 0 0 0 0 - 0
Total Income - EUR 26.171 7.759 7.640 7.500 7.354 7.214 6.428 925 - 348
Total Expenses - EUR 35.478 23.423 21.750 15.563 9.050 8.992 7.390 3.671 - 3.413
Gross Profit/Loss - EUR -9.307 -15.664 -14.110 -8.063 -1.696 -1.778 -962 -2.747 - -3.065
Net Profit/Loss - EUR -9.327 -15.664 -14.110 -8.063 -1.696 -1.778 -962 -2.747 - -3.065
Employees 2 1 1 1 0 0 0 0 - 0
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity as found at the Ministry of Finance. The data provides the evolution of the company during this period regarding the increases and possibly decreases recorded.
Sales - Ron
Net Profit - Ron
Employees

Check the financial reports for the company - Genome Life Research Srl

Rating financiar

Financial Rating -
GENOME LIFE RESEARCH SRL

See the company's note based on the submitted financial data, relative to the industry of which it is a part.

Financial Rating
Limite de plata

Payment Limits -
Genome Life Research Srl

See the company's payment capacity for situations in which you conclude contracts with payment terms.

Check Payment Limits
Probabilitate de insolventa

Prob. of insolvency -
Genome Life Research Srl

It determines the risk of insolvency based on the submitted accounting balance.

Insolvency Probability
Rapoarte financiare

Financial Reports -
Genome Life Research Srl

Check all the financial reports of the company and know the risks in collaboration with it.

Check Financial Reports
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.

Debts, Equity, Inventories, Receivables, Accounts, Assets - Genome Life Research Srl - CUI 31166896

2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Fixed Assets 56.082 46.142 36.873 27.864 19.153 10.774 3.392 696 - 0
Current Assets 15.593 1.244 1.574 1.856 1.817 1.764 2.039 2.046 - 2.028
Inventories 0 0 0 753 739 725 709 711 - 705
Receivables 14.298 1.180 1.565 1.109 1.087 1.048 1.339 1.343 - 1.332
Cash 1.294 64 9 -6 -9 -9 -9 -9 - -9
Shareholders Funds -48.534 -63.703 -76.735 -83.389 -83.470 -83.665 -82.505 -84.543 - -84.158
Social Capital 45 45 44 43 42 41 40 41 - 40
Debts 68.367 111.089 82.384 88.511 87.581 86.874 85.242 85.506 - 84.771
Income in Advance 52.386 41.133 32.797 24.696 16.864 9.330 2.695 1.778 - 1.415
Exchange rate - RON 4.9743 4.9465 4.9315 4.9468 4.8371 4.7454 4.6535 4.5681 4.4908 4.445
Main CAEN "7211 - 7211"
CAEN Financial Year 7211
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of 2.028 euro in 2024 which includes Inventories of 705 euro, Receivables of 1.332 euro and cash availability of -9 euro.
The company's Equity was valued at -84.158 euro, while total Liabilities amounted to 84.771 euro. Equity decreased by -342 euro, from -84.543 euro in 2022, to -84.158 in 2024. The Debt Ratio was 4,180.0% in the year 2024.

Risk Reports Prices

Reviews - Genome Life Research Srl

Comments - Genome Life Research Srl

Similar services useful for checking companies and business development.

SellNet

Get the contact details for any company and get in touch with it.

Sectoral Studies

Knows the market and develops its own development strategies according to sectorial data.

Databases

Export in excel files the data of the companies selected according to the desired criteria.

Import - Export

Find importers and exporters according to the type of activity and the countries in which they carry it out.

Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.